Lillian Tugume

Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study

Joshua Rhein, Bożena M Morawski, Kathy Huppler Hullsiek et al. · The Lancet Infectious Diseases · 2016 · 179 citations · Full text

Hiv-associated Cryptococcal Meningitis, Neurovirology, Adjunctive Sertraline +3

The current global situation for tuberculous meningitis: epidemiology, diagnostics, treatment and outcomes

James A. Seddon, Lillian Tugume, Regan Solomons et al. · Wellcome Open Research · 2019 · 127 citations · Full text

Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial

Joshua Rhein, Kathy Huppler Hullsiek, Lillian Tugume et al. · The Lancet Infectious Diseases · 2019 · 122 citations · Full text

Double-blind Phase 3, Hiv-associated Cryptococcal Meningitis, Neurovirology +3

Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study

Fiona V Cresswell, Lillian Tugume, Nathan C. Bahr et al. · The Lancet Infectious Diseases · 2020 · 115 citations · Full text

Improved diagnostic sensitivity for tuberculous meningitis with Xpert<SUP>®</SUP> MTB/RIF of centrifuged CSF

Nathan C. Bahr, Lillian Tugume, Radha Rajasingham et al. · The International Journal of Tuberculosis and Lung Disease · 2015 · 110 citations · Full text